Efficacy of the mHealth App Intellect in Improving Subclinical Obsessive-Compulsive Disorder in University Students: Randomized Controlled Trial With a 4-Week Follow-Up.
Autor: | Lee Yoon Li M; National University of Singapore, Singapore, Singapore., Lee Si Min S; National University of Singapore, Singapore, Singapore., Sündermann O; National University of Singapore, Singapore, Singapore. |
---|---|
Jazyk: | angličtina |
Zdroj: | JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2024 Dec 16; Vol. 12, pp. e63316. Date of Electronic Publication: 2024 Dec 16. |
DOI: | 10.2196/63316 |
Abstrakt: | Background: Obsessive-compulsive disorder (OCD) is the third most prevalent mental health disorder in Singapore, with a high degree of burden and large treatment gaps. Self-guided programs on mobile apps are accessible and affordable interventions, with the potential to address subclinical OCD before symptoms escalate. Objective: This randomized controlled trial aimed to examine the efficacy of a self-guided OCD program on the mobile health (mHealth) app Intellect in improving subclinical OCD and maladaptive perfectionism (MP) as a potential moderator of this predicted relationship. Methods: University students (N=225) were randomly assigned to an 8-day, self-guided app program on OCD (intervention group) or cooperation (active control). Self-reported measures were obtained at baseline, after the program, and at a 4-week follow-up. The primary outcome measure was OCD symptom severity (Obsessive Compulsive Inventory-Revised [OCI-R]). Baseline MP was assessed as a potential moderator. Depression, anxiety, and stress (Depression Anxiety and Stress Scales-21) were controlled for during statistical analyses. Results: The final sample included 192 participants. The intervention group reported significantly lower OCI-R scores compared with the active control group after the intervention (partial eta-squared [η Conclusions: This study provides evidence that the self-guided OCD program on the Intellect app is effective in reducing subclinical OCD among university students in Singapore. Future studies should include longer follow-up durations and study MP as a moderator in a broader spectrum of OCD symptom severity. Trial Registration: ClinicalTrials.gov NCT06202677; https://clinicaltrials.gov/study/NCT06202677. (©Madeline Lee Yoon Li, Stephanie Lee Si Min, Oliver Sündermann. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 16.12.2024.) |
Databáze: | MEDLINE |
Externí odkaz: |